News Releases

Jul 03, 2020
Applied Therapeutics Takes Action Against Fraudulent “Short Report”
On July 1, 2020, a fraudulent “short report” was posted. The fraudulent report includes manipulated company graphs and figures, fraudulent misrepresentation of data, and factual misstatements. Applied Therapeutics will work with law enforcement and regulators to ensure this criminal stock
May 12, 2020
Applied Therapeutics to Present at the UBS Global Healthcare Conference
NEW YORK , May 12, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, announced today that it will present at the
May 11, 2020
Applied Therapeutics Reports First Quarter 2020 Financial Results
NEW YORK , May 11, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported financial results for the
Displaying 1 - 10 of 18